Global Multiple Sclerosis Market and Competitive Landscape - 2017

  • ID: 4377448
  • Report
  • Region: Global
  • Fore Pharma
1 of 3
The latest research, Global Multiple Sclerosis Market and Competitive Landscape - 2017, provides comprehensive insights into Multiple Sclerosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Multiple Sclerosis market size and drug sales. This research also provides insights into Multiple Sclerosis epidemiology and late stage pipeline.

The report is classified into twelve sections - Multiple Sclerosis overview with definitions, symptoms, etiology, diagnosis, treatment options; Multiple Sclerosis pipeline insights covering late stage clinical trials pipeline; Multiple Sclerosis prevalence trends by countries; Multiple Sclerosis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:
  • Multiple Sclerosis pipeline: Find out the drugs in clinical trials for Multiple Sclerosis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Multiple Sclerosis epidemiology: Find out the prevalence of Multiple Sclerosis by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Multiple Sclerosis products: Identify key products marketed and prescribed for Multiple Sclerosis by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Sclerosis market size: Find out the market size for Multiple Sclerosis drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Multiple Sclerosis drug sales: Find out the sales of Multiple Sclerosis drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Multiple Sclerosis drugs sales forecast: Sales forecast for Multiple Sclerosis drugs to 2021 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Sclerosis market share analysis: Find out the market shares of Multiple Sclerosis drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Multiple Sclerosis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Multiple Sclerosis market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Multiple Sclerosis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Multiple Sclerosis: Disease Overview
1.1. Multiple Sclerosis Symptoms
1.2. Multiple Sclerosis Etiology
1.3. Multiple Sclerosis Diagnosis
1.4. Multiple Sclerosis Treatment Options

2. Multiple Sclerosis Pipeline Insights
2.1. Multiple Sclerosis Phase 3 Clinical Trials
2.2. Multiple Sclerosis Phase 2 Clinical Trials
2.3. Multiple Sclerosis Phase 1 Clinical Trials

3. Multiple Sclerosis Epidemiology Analysis

4. US Multiple Sclerosis Market Insights
4.1. Marketed Products for Multiple Sclerosis in US
4.2. US Multiple Sclerosis Market Size & Forecast
4.3. US Multiple Sclerosis Product Sales Forecast
4.4. US Multiple Sclerosis Market Share Analysis

5. Germany Multiple Sclerosis Market Insights
5.1. Marketed Products for Multiple Sclerosis in Germany
5.2. Germany Multiple Sclerosis Market Size & Forecast
5.3. Germany Multiple Sclerosis Product Sales Forecast
5.4. Germany Multiple Sclerosis Market Share Analysis

6. France Multiple Sclerosis Market Insights
6.1. Marketed Products for Multiple Sclerosis in France
6.2. France Multiple Sclerosis Market Size & Forecast
6.3. France Multiple Sclerosis Product Sales Forecast
6.4. France Multiple Sclerosis Market Share Analysis

7. Italy Multiple Sclerosis Market Insights
7.1. Marketed Products for Multiple Sclerosis in Italy
7.2. Italy Multiple Sclerosis Market Size & Forecast
7.3. Italy Multiple Sclerosis Product Sales Forecast
7.4. Italy Multiple Sclerosis Market Share Analysis

8. Spain Multiple Sclerosis Market Insights
8.1. Marketed Products for Multiple Sclerosis in Spain
8.2. Spain Multiple Sclerosis Market Size & Forecast
8.3. Spain Multiple Sclerosis Product Sales Forecast
8.4. Spain Multiple Sclerosis Market Share Analysis

9. UK Multiple Sclerosis Market Insights
9.1. Marketed Products for Multiple Sclerosis in UK
9.2. UK Multiple Sclerosis Market Size & Forecast
9.3. UK Multiple Sclerosis Product Sales Forecast
9.4. UK Multiple Sclerosis Market Share Analysis

10. Europe Multiple Sclerosis Market Insights
10.1. Europe Multiple Sclerosis Market Size & Forecast
10.2. Europe Multiple Sclerosis Product Sales Forecast
10.3. Europe Multiple Sclerosis Market Share Analysis

11. Japan Multiple Sclerosis Market Insights
11.1. Marketed Products for Multiple Sclerosis in Japan
11.2. Japan Multiple Sclerosis Market Size & Forecast
11.3. Japan Multiple Sclerosis Product Sales Forecast
11.4. Japan Multiple Sclerosis Market Share Analysis

12. Global Multiple Sclerosis Market Insights
12.1. Global Multiple Sclerosis Market Size & Forecast
12.2. Global Multiple Sclerosis Product Sales Forecast
12.3. Global Multiple Sclerosis Market Share Analysis

13. Research Methodology

List of Tables:
Table 1: Multiple Sclerosis Phase 3 Clinical Trials, Global, 2017
Table 2: Multiple Sclerosis Phase 2 Clinical Trials, Global, 2017
Table 3: Multiple Sclerosis Phase 1 Clinical Trials, Global, 2017
Table 4: Multiple Sclerosis Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Multiple Sclerosis in US, 2017
Table 6: US Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 8: US Multiple Sclerosis Market Trends, 2012 - 2021
Table 9: Marketed Products for Multiple Sclerosis in Germany, 2017
Table 10: Germany Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 12: Germany Multiple Sclerosis Market Trends, 2012 - 2021
Table 13: Marketed Products for Multiple Sclerosis in France, 2017
Table 14: France Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 16: France Multiple Sclerosis Market Trends, 2012 - 2021
Table 17: Marketed Products for Multiple Sclerosis in Italy, 2017
Table 18: Italy Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 20: Italy Multiple Sclerosis Market Trends, 2012 - 2021
Table 21: Marketed Products for Multiple Sclerosis in Spain, 2017
Table 22: Spain Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 24: Spain Multiple Sclerosis Market Trends, 2012 - 2021
Table 25: Marketed Products for Multiple Sclerosis in UK, 2017
Table 26: UK Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 28: UK Multiple Sclerosis Market Trends, 2012 - 2021
Table 29: Europe Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Multiple Sclerosis in Japan, 2017
Table 32: Japan Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 34: Japan Multiple Sclerosis Market Trends, 2012 - 2021
Table 35: Global Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Multiple Sclerosis Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Multiple Sclerosis Pipeline by Phase (%), Global, 2017
Figure 2: Multiple Sclerosis Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 4: US Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 5: US Multiple Sclerosis Market Share by Products (%), 2016
Figure 6: US Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 7: Germany Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 8: Germany Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 9: Germany Multiple Sclerosis Market Share by Products (%), 2016
Figure 10: Germany Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 11: France Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 12: France Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 13: France Multiple Sclerosis Market Share by Products (%), 2016
Figure 14: France Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 15: Italy Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 16: Italy Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 17: Italy Multiple Sclerosis Market Share by Products (%), 2016
Figure 18: Italy Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 19: Spain Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 20: Spain Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 21: Spain Multiple Sclerosis Market Share by Products (%), 2016
Figure 22: Spain Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 23: UK Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 24: UK Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 25: UK Multiple Sclerosis Market Share by Products (%), 2016
Figure 26: UK Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 27: Europe Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 28: Europe Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 29: Europe Multiple Sclerosis Market Share by Products (%), 2016
Figure 30: Europe Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 31: Japan Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 32: Japan Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 33: Japan Multiple Sclerosis Market Share by Products (%), 2016
Figure 34: Japan Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 35: Global Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 36: Global Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 37: Global Multiple Sclerosis Market Share by Products (%), 2016
Figure 38: Global Multiple Sclerosis Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll